Tag: HIV response

Zimbabwe’s Medicines Regulatory Body Registers Lencapavir

Michael Gwarisa

By Michael Gwarisa The Medicines Control Authority of Zimbabwe (MCAZ) has announced the expedited approval of Lenacapavir, an innovative long-acting medicine for pre exposure prophylaxis (PrEP) to prevent HIV-1 infection. The MCAZ Director-General, Mr. Richard T. Rukwata, said “the rapid approval of Lenacapavir reflects the Authority’s dedication to accelerating access to trusted, high-quality health products and brings new hope for HIV prevention while reinforcing its commitment to safeguarding public health.” Lenacapavir was assessed and approved by the Registration Committee under the expedited review process, as it is considered to be…

Read More

US Unveils $65 Million Bridge Plan to Sustain Zimbabwe’s HIV Respons

Michael Gwarisa

By Michael Gwarisa The United States Department of State, through the President’s Emergency Plan for AIDS Relief (PEPFAR), has unveiled a new HIV and AIDS support fund worth US$65.1 million for Zimbabwe. The initiative, known as The Bridge Plan, will run for the next six months, with renewal contingent on the Government of Zimbabwe meeting new U.S. Government (USG) funding requirements. Under the Bridge Plan, the U.S. government will continue to support critical HIV interventions such as antiretroviral therapy (ART) and HIV commodities procurement. However, the new funding excludes certain…

Read More

Global Fund Appeals for Support Ahead of 8th Replenishment, Calls for African Ownership of HIV Programs

Michael Gwarisa

By Michael Gwarisa in Durban The Global Fund last night took to the platform at the ongoing 4th CPHIA Conference in Durban, South Africa, to call for support towards the 8th Replenishment, aimed at strengthening HIV programs amid shrinking donor support. The Global Fund’s 8th Replenishment is a campaign launched in 2025 to raise 18 billion US dollars to fight HIV, TB, and malaria between 2027 and 2029. The 8th cycle aims to save 23 million lives, avert 400 million infections, reduce mortality by 64% compared to 2023, and strengthen…

Read More